Compare Agilent Technologies Inc (A) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Xcel Energy Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Xcel Energy Inc trades at $77.66 (market cap $48.02B). The key difference: Agilent Technologies Inc and Xcel Energy Inc are close in size by market cap, and Xcel Energy Inc pays the higher dividend (3.08%). Which is the better fit depends on your goals.
| A | XEL | |
|---|---|---|
Market Cap | $42.00B | $48.02B |
Sector | Health | Utilities |
52-Week High | $157.20 | $83.91 |
52-Week Low | $110.24 | $71.75 |
Enterprise Value | $43.55B | $86.33B |
Dividend Yield | 0.69% | 3.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Xcel Energy (XEL) trades at $78.07, up 1.43% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $0.93 per share, beating estimates, driven by infrastructure investment recovery. Revenue for 2025 was $14.67B with a net income margin of 15.28%, while the balance sheet shows rising assets and liabilities, with a debt-to-asset ratio of 41.57% in 2024. Recent news highlights community investment and board additions.
The outlook for XEL is supported by a $60 billion capital plan targeting 11% annual rate base growth, but regulatory pushback and affordability concerns pose risks. Analyst consensus is bullish with a $93.80 price target, implying 20% upside, though technical indicators suggest near-term caution. Earnings growth and utility demand trends remain key catalysts for investor returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
